Demant (CPH: DEMANT) revenue
Demant reported revenue of DKK 22,971m for fiscal 2025, 2.5% more than in fiscal 2024 (DKK 22,419m). Since fiscal 2019 its revenue has grown by 53.7%, an average growth of 7.4% a year.
Demant has grown its revenue for 5 years in a row, and fiscal 2025 is the highest of its 7 fiscal years on record. The biggest drop was in fiscal 2020, −3.2%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | DKK 22,971m | +2.5% | DKK 3,832m | 16.7% |
| 2024 | DKK 22,419m | +3.8% | DKK 4,528m | 20.2% |
| 2023 | DKK 21,601m | +9.6% | DKK 4,506m | 20.9% |
| 2022 | DKK 19,705m | +10.1% | DKK 3,207m | 16.3% |
| 2021 | DKK 17,905m | +23.7% | DKK 3,663m | 20.5% |
| 2020 | DKK 14,469m | −3.2% | DKK 1,530m | 10.6% |
| 2019 | DKK 14,946m | — | DKK 2,151m | 14.4% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of Danish kroner, except per-share amounts.
Demant revenue compared with its sector
By revenue for its latest fiscal year, Demant ranks 15th of the 59 Spanish and European health care companies with a page on Celsmar. The sector median grew 4.5% in its latest fiscal year; Demant, 2.5%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 13th | Genmab | $3,720m | 19.2% |
| 14th | Getinge | SEK 34,969m | 0.6% |
| 15th | Demant | DKK 22,971m | 2.5% |
| 16th | Hikma Pharmaceuticals | $3,349m | 7.1% |
| 17th | Sartorius Stedim Biotech | €2,968m | 6.7% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in health care stocks.
Questions about the revenue of Demant
- How much revenue did Demant make in fiscal 2025?
- Demant reported revenue of DKK 22,971m for fiscal 2025, compared with DKK 22,419m in fiscal 2024.
- How much has the revenue of Demant grown?
- Between fiscal 2019 and fiscal 2025 it went from DKK 14,946m to DKK 22,971m: 53.7% more, an average growth of 7.4% a year.
- What was the best year for revenue at Demant?
- Of its last 7 fiscal years, fiscal 2025, with DKK 22,971m.
- Where does Demant rank in its sector by revenue?
- It ranks 15th of the 59 Spanish and European health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Demant come from?
- From the report Demant files every year in the European single electronic format (ESEF), the one it files with the regulator of its home market. Each fiscal year links to its filing.
Where each figure comes from
From the annual report Demant files every year in the European single electronic format (ESEF). The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020. More on Demant: the Demant page · annual accounts · net income.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.